Induced pluripotent stem cell modeling of Gaucher's disease: what have we learned?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.1/11082 |
Resumo: | Gaucher's disease (GD) is the most frequently inherited lysosomal storage disease, presenting both visceral and neurologic symptoms. Mutations in acid beta-glucocerebrosidase disrupt the sphingolipid catabolic pathway promoting glucosylceramide (GlcCer) accumulation in lysosomes. Current treatment options are enzyme replacement therapy (ERT) and substrate reduction therapy (SRT). However, neither of these approaches is effective in treating the neurological aspect of the disease. The use of small pharmacological compounds that act as molecular chaperones is a promising approach that is still experimental. In recent years, an association between GD and Parkinson like synucleinopathies has been discovered. Since 1992, a number of mouse models of GD have been the developed and partially reproduce phenotype of the disease. More recently, the discovery of direct reprograming has allowed the derivation of induced pluripotent stem cells (iPSc) from fibroblasts obtained from GD patients. iPSc can be expanded indefinitely in vitro and differentiated to macrophages and neurons, the main relevant cell types involved in GD. In this work, we review iPSc models of GD and summarize what we have learned from this system. |
id |
RCAP_0ec399d1ac5de77d912a962fd1d2e250 |
---|---|
oai_identifier_str |
oai:sapientia.ualg.pt:10400.1/11082 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Induced pluripotent stem cell modeling of Gaucher's disease: what have we learned?Acid-Beta-glucosidaseGlucocerebrosidase gene-mutationsLysosomal storage diseasesParkinsons-diseaseAlpha-synucleinMouse modelPharmacological chaperonesTargeted disruptionCalcium homeostasisDown-regulationGaucher's disease (GD) is the most frequently inherited lysosomal storage disease, presenting both visceral and neurologic symptoms. Mutations in acid beta-glucocerebrosidase disrupt the sphingolipid catabolic pathway promoting glucosylceramide (GlcCer) accumulation in lysosomes. Current treatment options are enzyme replacement therapy (ERT) and substrate reduction therapy (SRT). However, neither of these approaches is effective in treating the neurological aspect of the disease. The use of small pharmacological compounds that act as molecular chaperones is a promising approach that is still experimental. In recent years, an association between GD and Parkinson like synucleinopathies has been discovered. Since 1992, a number of mouse models of GD have been the developed and partially reproduce phenotype of the disease. More recently, the discovery of direct reprograming has allowed the derivation of induced pluripotent stem cells (iPSc) from fibroblasts obtained from GD patients. iPSc can be expanded indefinitely in vitro and differentiated to macrophages and neurons, the main relevant cell types involved in GD. In this work, we review iPSc models of GD and summarize what we have learned from this system.Program for Regenerative Medicine PhD Fellowship; Genzyme CorporationMDPI AgSapientiaSantos Matias, DinoTiscornia, Gustavo2018-12-07T14:52:26Z2017-042017-04-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.1/11082eng1422-006710.3390/ijms18040888info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-24T10:22:49Zoai:sapientia.ualg.pt:10400.1/11082Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:02:36.728116Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Induced pluripotent stem cell modeling of Gaucher's disease: what have we learned? |
title |
Induced pluripotent stem cell modeling of Gaucher's disease: what have we learned? |
spellingShingle |
Induced pluripotent stem cell modeling of Gaucher's disease: what have we learned? Santos Matias, Dino Acid-Beta-glucosidase Glucocerebrosidase gene-mutations Lysosomal storage diseases Parkinsons-disease Alpha-synuclein Mouse model Pharmacological chaperones Targeted disruption Calcium homeostasis Down-regulation |
title_short |
Induced pluripotent stem cell modeling of Gaucher's disease: what have we learned? |
title_full |
Induced pluripotent stem cell modeling of Gaucher's disease: what have we learned? |
title_fullStr |
Induced pluripotent stem cell modeling of Gaucher's disease: what have we learned? |
title_full_unstemmed |
Induced pluripotent stem cell modeling of Gaucher's disease: what have we learned? |
title_sort |
Induced pluripotent stem cell modeling of Gaucher's disease: what have we learned? |
author |
Santos Matias, Dino |
author_facet |
Santos Matias, Dino Tiscornia, Gustavo |
author_role |
author |
author2 |
Tiscornia, Gustavo |
author2_role |
author |
dc.contributor.none.fl_str_mv |
Sapientia |
dc.contributor.author.fl_str_mv |
Santos Matias, Dino Tiscornia, Gustavo |
dc.subject.por.fl_str_mv |
Acid-Beta-glucosidase Glucocerebrosidase gene-mutations Lysosomal storage diseases Parkinsons-disease Alpha-synuclein Mouse model Pharmacological chaperones Targeted disruption Calcium homeostasis Down-regulation |
topic |
Acid-Beta-glucosidase Glucocerebrosidase gene-mutations Lysosomal storage diseases Parkinsons-disease Alpha-synuclein Mouse model Pharmacological chaperones Targeted disruption Calcium homeostasis Down-regulation |
description |
Gaucher's disease (GD) is the most frequently inherited lysosomal storage disease, presenting both visceral and neurologic symptoms. Mutations in acid beta-glucocerebrosidase disrupt the sphingolipid catabolic pathway promoting glucosylceramide (GlcCer) accumulation in lysosomes. Current treatment options are enzyme replacement therapy (ERT) and substrate reduction therapy (SRT). However, neither of these approaches is effective in treating the neurological aspect of the disease. The use of small pharmacological compounds that act as molecular chaperones is a promising approach that is still experimental. In recent years, an association between GD and Parkinson like synucleinopathies has been discovered. Since 1992, a number of mouse models of GD have been the developed and partially reproduce phenotype of the disease. More recently, the discovery of direct reprograming has allowed the derivation of induced pluripotent stem cells (iPSc) from fibroblasts obtained from GD patients. iPSc can be expanded indefinitely in vitro and differentiated to macrophages and neurons, the main relevant cell types involved in GD. In this work, we review iPSc models of GD and summarize what we have learned from this system. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-04 2017-04-01T00:00:00Z 2018-12-07T14:52:26Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.1/11082 |
url |
http://hdl.handle.net/10400.1/11082 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1422-0067 10.3390/ijms18040888 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
MDPI Ag |
publisher.none.fl_str_mv |
MDPI Ag |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799133260774637568 |